Completed OBSERVATIONAL NCT07030842
Precision Recurrence Risk Assessment in Early-stage Hepatocellular Carcinoma
Multimodal Deep Learning Models for Predicting Recurrence Pattern in Hepatocellular Carcinoma: A Multicenter Retrospective Development and Validation Study
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Conditions
Hepatocellular Carcinoma (HCC)
Interventions
liver resection
Updated 1 time since 2025 Last updated: Jun 27, 2025 Started: Aug 25, 2023 Primary completion: Jul 30, 2024 Completion: Jul 30, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This observational or N/A phase trial investigates Hepatocellular Carcinoma (HCC) and is currently completed. Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University leads this study, which shows 1 recorded version since 2023 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
1 version recorded Completed
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Tongji Hospital
Data source: Tongji Hospital
For direct contact, visit the study record on ClinicalTrials.gov .